Keisuke Kamada

850 total citations
42 papers, 304 citations indexed

About

Keisuke Kamada is a scholar working on Infectious Diseases, Epidemiology and Surgery. According to data from OpenAlex, Keisuke Kamada has authored 42 papers receiving a total of 304 indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Infectious Diseases, 20 papers in Epidemiology and 13 papers in Surgery. Recurrent topics in Keisuke Kamada's work include Mycobacterium research and diagnosis (10 papers), Tuberculosis Research and Epidemiology (10 papers) and COVID-19 Clinical Research Studies (5 papers). Keisuke Kamada is often cited by papers focused on Mycobacterium research and diagnosis (10 papers), Tuberculosis Research and Epidemiology (10 papers) and COVID-19 Clinical Research Studies (5 papers). Keisuke Kamada collaborates with scholars based in Japan, United States and Germany. Keisuke Kamada's co-authors include Ken Kikuchi, Shigekazu Iguchi, Sho Nakakubo, Satoshi Konno, Yu Yamashita, Yūkō Arai, Satoshi Konno, Masaru Suzuki, Junichi Nakamura and Yasuyuki Nasuhara and has published in prestigious journals such as Scientific Reports, Antimicrobial Agents and Chemotherapy and The Lancet Infectious Diseases.

In The Last Decade

Keisuke Kamada

32 papers receiving 298 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Keisuke Kamada Japan 11 224 138 53 34 34 42 304
Tracy McMillen United States 12 292 1.3× 184 1.3× 44 0.8× 60 1.8× 37 1.1× 25 463
Lore Vanderbeke Belgium 9 299 1.3× 186 1.3× 51 1.0× 41 1.2× 59 1.7× 13 373
Ioannis Pavleas Greece 4 376 1.7× 195 1.4× 40 0.8× 15 0.4× 17 0.5× 6 419
Ralph Tayyar United States 8 99 0.4× 139 1.0× 33 0.6× 23 0.7× 15 0.4× 18 246
Hasan Selçuk Özger Türkiye 9 196 0.9× 66 0.5× 88 1.7× 72 2.1× 19 0.6× 47 340
Teny M. John United States 8 344 1.5× 113 0.8× 81 1.5× 24 0.7× 26 0.8× 24 442
Montserrat Ruiz‐García Spain 12 110 0.5× 158 1.1× 13 0.2× 32 0.9× 34 1.0× 20 338
Reshu Agarwal India 9 186 0.8× 152 1.1× 9 0.2× 28 0.8× 25 0.7× 43 291
Silvana Sanna Italy 9 185 0.8× 90 0.7× 25 0.5× 15 0.4× 65 1.9× 22 323
Immaculata Xess India 7 555 2.5× 270 2.0× 73 1.4× 11 0.3× 20 0.6× 27 611

Countries citing papers authored by Keisuke Kamada

Since Specialization
Citations

This map shows the geographic impact of Keisuke Kamada's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Keisuke Kamada with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Keisuke Kamada more than expected).

Fields of papers citing papers by Keisuke Kamada

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Keisuke Kamada. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Keisuke Kamada. The network helps show where Keisuke Kamada may publish in the future.

Co-authorship network of co-authors of Keisuke Kamada

This figure shows the co-authorship network connecting the top 25 collaborators of Keisuke Kamada. A scholar is included among the top collaborators of Keisuke Kamada based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Keisuke Kamada. Keisuke Kamada is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Kodama, Tatsuya, Akio Aono, Keiji Fujiwara, et al.. (2025). Risk factors, molecular analysis and treatment outcomes of amikacin-resistant Mycobacterium avium complex pulmonary disease. ERJ Open Research. 11(4). 1084–2024.
2.
3.
Kikuchi, Shinsuke, Kazuki Takahashi, Keisuke Kamada, et al.. (2025). Clinical Features of Acute on Chronic Lower Limb Ischemia and the Importance of Underlying Arterial Disease for Revascularization. Circulation Reports. 7(3). 168–175.
4.
Aono, Akio, Keiji Fujiwara, Takahiro Asami, et al.. (2024). In vitro effects of the new oral β-lactamase inhibitor xeruborbactam in combination with oral β-lactams against clinical Mycobacterium abscessus isolates. Microbiology Spectrum. 12(7). e0008424–e0008424. 3 indexed citations
5.
Chikamatsu, Kazuaki, Keisuke Kamada, Kazue Mizuno, et al.. (2024). Evaluation of testing face-mask filter samples with LAMP shows high rates of detection in pulmonary TB. The International Journal of Tuberculosis and Lung Disease. 28(10). 476–481.
6.
Kikuchi, Shinsuke, et al.. (2024). Super-Elderly Case of Acute Lower Limb Ischemia Treated with Indigo Aspiration System in Japan. Annals of Vascular Diseases. 17(1). 63–68. 1 indexed citations
7.
Oyama, Kyohei, et al.. (2024). Hypothermic circulatory arrest at 20 ℃ does not deteriorate coagulopathy compared to 28 ℃ in a pig model. Journal of Artificial Organs. 28(1). 36–42. 1 indexed citations
8.
Fujiwara, Keiji, Akio Aono, Takahiro Asami, et al.. (2023). In Vitro Synergistic Effects of Omadacycline with Other Antimicrobial Agents against Mycobacterium abscessus. Antimicrobial Agents and Chemotherapy. 67(6). e0157922–e0157922. 8 indexed citations
9.
Ueda, Yasuhiro, Takayuki Okamoto, Yasuyuki Sato, et al.. (2022). Kidney transplantation after peritoneal dialysis-associated peritonitis and abdominal abscesses caused by Mycobacterium massiliense: lesson for the clinical nephrologist. Journal of Nephrology. 35(7). 1907–1910. 2 indexed citations
10.
Kojima, Yuichi, Sho Nakakubo, Keisuke Kamada, et al.. (2022). Comparative Efficacy of Tocilizumab and Baricitinib Administration in COVID-19 Treatment: A Retrospective Cohort Study. Medicina. 58(4). 513–513. 18 indexed citations
11.
12.
13.
Kamada, Keisuke & Satoshi Mitarai. (2021). Anti-Mycobacterial Drug Resistance in Japan: How to Approach This Problem?. Antibiotics. 11(1). 19–19. 3 indexed citations
14.
Takenouchi, Toshiki, Mamiko Yamada, Hisato Suzuki, et al.. (2021). Multiple introductions of SARS-CoV-2 B.1.1.214 lineages from mainland Japan preceded the third wave of the COVID-19 epidemic in Hokkaido. Travel Medicine and Infectious Disease. 44. 102210–102210. 3 indexed citations
15.
Kamada, Keisuke, Shigekazu Iguchi, Yūkō Arai, et al.. (2021). Nationwide surveillance of antimicrobial susceptibility of 509 rapidly growing mycobacteria strains isolated from clinical specimens in Japan. Scientific Reports. 11(1). 12208–12208. 23 indexed citations
16.
Kamada, Keisuke, Satoshi Konno, Takeshi Kaneko, et al.. (2021). The effect of the outbreak of COVID-19 on respiratory physicians and healthcare in Japan: Serial nationwide surveys by the Japanese Respiratory Society. Respiratory Investigation. 59(6). 792–798. 2 indexed citations
17.
Kamada, Keisuke, et al.. (2020). Rapidly progressive organizing pneumonia associated with COVID-19. Respiratory Medicine Case Reports. 31. 101295–101295. 14 indexed citations
18.
Iguchi, Shigekazu, et al.. (2019). Candida auris: A pathogen difficult to identify, treat, and eradicate and its characteristics in Japanese strains. Journal of Infection and Chemotherapy. 25(10). 743–749. 46 indexed citations
19.
Sugiyama, Kazuhiro, Takahiro Tanabe, Yasuhiro Wada, et al.. (2018). Purpura fulminans with Lemierre’s syndrome caused by Gemella bergeri and Eikenella corrodens: a case report. BMC Infectious Diseases. 18(1). 523–523. 6 indexed citations
20.
Shinjoh, Masayoshi, Toshinao Kawai, Isamu Kamimaki, et al.. (2018). Purulent lymphadenitis caused by Staphylococcus argenteus, representing the first Japanese case of Staphylococcus argenteus (multilocus sequence type 2250) infection in a 12-year-old boy. Journal of Infection and Chemotherapy. 24(11). 925–927. 25 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Tracy McMillen Breakdown of academic impact, for papers by Lore Vanderbeke Breakdown of academic impact, for papers by Ioannis Pavleas Breakdown of academic impact, for papers by Ralph Tayyar Breakdown of academic impact, for papers by Hasan Selçuk Özger Breakdown of academic impact, for papers by Teny M. John Breakdown of academic impact, for papers by Montserrat Ruiz‐García Breakdown of academic impact, for papers by Reshu Agarwal Breakdown of academic impact, for papers by Silvana Sanna Breakdown of academic impact, for papers by Immaculata Xess
Rankless by CCL
2026